Lung cancer is one of the most challenging diseases, making early diagnosis crucial for effective treatment. Fortunately, advancements in artificial intelligence (AI) are transforming lung cancer screening, improving both accuracy and efficiency.

Biotechnology researchers at Rensselaer Polytechnic Institute (RPI) are working to further improve mRNA therapeutics, with the aim of reducing manufacturing costs and enabling additional therapeutic uses for mRNA technology.

The Rensselaer Cybersecurity Collaboratory (RCC) continues to make its mark in the world of Capture the Flag (CTF) competitions, with two impressive performances this academic year.